Lapatinib Ditosylate API - Global Top Players Market Share and Ranking 2025- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Lapatinib Ditosylate API - Global Top Players Market Share and Ranking 2025

Lapatinib Ditosylate API - Global Top Players Market Share and Ranking 2025

Publication Date: 2025-11-15
Report Id: 2768769
Industry: Pharma & Healthcare
Report Page: 101
Chart: 108

PDF Download

Publication Date: 2025-11-15
Report Id: 2768769
Industry: Pharma & Healthcare
Report Page: 101
Chart: 108

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Lapatinib Ditosylate API Definition
1.2 Global Lapatinib Ditosylate API Market Size and Forecast
1.2.1 By Consumption Value, Global Lapatinib Ditosylate API Market Size, 2020-2031
1.2.2 By Sales Quantity, Global Lapatinib Ditosylate API Market Size, 2020-2031
1.2.3 Global Lapatinib Ditosylate API Average Selling Price (ASP), 2020-2031
1.3 China Lapatinib Ditosylate API Market Size and Forecast
1.3.1 By Consumption Value, China Lapatinib Ditosylate API Market Size, 2020-2031
1.3.2 By Sales Quantity, China Lapatinib Ditosylate API Market Size, 2020-2031
1.3.3 China Lapatinib Ditosylate API Average Selling Price (ASP), 2020-2031
1.4 Share of China Lapatinib Ditosylate API Market with Respect to the Global Market
1.4.1 By Consumption Value, China Lapatinib Ditosylate API Market Share in Global, 2020-2031
1.4.2 By Sales Quantity, China Lapatinib Ditosylate API Market Share in Global, 2020-2031
1.4.3 Lapatinib Ditosylate API Market Size: China VS Global, 2020-2031
1.5 Lapatinib Ditosylate API Market Dynamics
1.5.1 Lapatinib Ditosylate API Market Drivers
1.5.2 Lapatinib Ditosylate API Market Restraints
1.5.3 Lapatinib Ditosylate API Industry Trends
1.5.4 Lapatinib Ditosylate API Industry Policy

2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Lapatinib Ditosylate API, Global Market Share by Company, 2020-2025
2.2 By Sales Quantity of Lapatinib Ditosylate API, Global Market Share by Company, 2020-2025
2.3 Lapatinib Ditosylate API Average Selling Price (ASP) by Company, 2020-2025
2.4 Global Lapatinib Ditosylate API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Lapatinib Ditosylate API Concentration Ratio
2.6 Global Lapatinib Ditosylate API Mergers & Acquisitions, Expansion Plans
2.7 Global Lapatinib Ditosylate API Manufacturers Product Type
2.8 Head Office and Lapatinib Ditosylate API Production Site of Key Manufacturer
2.9 Lapatinib Ditosylate API Capacity of Major Manufacturers and Future Plan

3 China Leading Manufacturers and Market Share
3.1 By Revenue of Lapatinib Ditosylate API, China Market Share by Company, 2020-2025
3.2 By Sales Quantity of Lapatinib Ditosylate API, China Market Share by Company, 2020-2025
3.3 China Lapatinib Ditosylate API Lapatinib Ditosylate API Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Global Producing Regions
4.1 Global Lapatinib Ditosylate API Capacity, Output and Capacity Utilization, 2020-2031
4.2 Global Lapatinib Ditosylate API Capacity by Region
4.3 Global Lapatinib Ditosylate API Production & Forecast by Region, 2020 VS 2024 VS 2031
4.4 Global Lapatinib Ditosylate API Production by Region, 2020-2031
4.5 Global Lapatinib Ditosylate API Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Lapatinib Ditosylate API Industry Chain
5.2 Lapatinib Ditosylate API Upstream Analysis
5.2.1 Lapatinib Ditosylate API Core Raw Materials
5.2.2 Main Manufacturers of Lapatinib Ditosylate API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Lapatinib Ditosylate API Production Mode
5.6 Lapatinib Ditosylate API Procurement Model
5.7 Lapatinib Ditosylate API Industry Sales Model and Sales Channels
5.7.1 Lapatinib Ditosylate API Sales Model
5.7.2 Lapatinib Ditosylate API Typical Distributors

6 Sights by Type
6.1 Lapatinib Ditosylate API Classification by Type
6.1.1 Lapatinib Ditosylate Hydrate
6.1.2 Anhydrous Lapatinib Ditosylate
6.2 by Type, Global Lapatinib Ditosylate API Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
6.4 by Type, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
6.5 by Type, Global Lapatinib Ditosylate API Average Selling Price (ASP), 2020-2031

7 Sights by Production Process
7.1 Lapatinib Ditosylate API Classification by Production Process
7.1.1 Chemical Synthesis Route
7.1.2 Continuous Flow Process
7.1.3 Other
7.2 by Production Process, Global Lapatinib Ditosylate API Consumption Value & CAGR, 2020 VS 2024 VS 2031
7.3 by Production Process, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
7.4 by Production Process, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
7.5 by Production Process, Global Lapatinib Ditosylate API Average Selling Price (ASP), 2020-2031

8 Sights by Product Type
8.1 Lapatinib Ditosylate API Classification by Product Type
8.1.1 Crystalline Form
8.1.2 Amorphous Form
8.2 by Product Type, Global Lapatinib Ditosylate API Consumption Value & CAGR, 2020 VS 2024 VS 2031
8.3 by Product Type, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
8.4 by Product Type, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
8.5 by Product Type, Global Lapatinib Ditosylate API Average Selling Price (ASP), 2020-2031

9 Sights by Application
9.1 Lapatinib Ditosylate API Segment by Application
9.1.1 Research
9.1.2 Pharmaceutical
9.2 by Application, Global Lapatinib Ditosylate API Consumption Value & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
9.4 by Application, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
9.5 by Application, Global Lapatinib Ditosylate API Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Lapatinib Ditosylate API Consumption Value, 2020 VS 2024 VS 2031
10.2 By Region, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
10.3 By Region, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
10.4 North America
10.4.1 North America Lapatinib Ditosylate API Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Lapatinib Ditosylate API Market Size Market Share
10.5 Europe
10.5.1 Europe Lapatinib Ditosylate API Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Lapatinib Ditosylate API Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Lapatinib Ditosylate API Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Lapatinib Ditosylate API Market Size Market Share
10.7 South America
10.7.1 South America Lapatinib Ditosylate API Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Lapatinib Ditosylate API Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Lapatinib Ditosylate API Market Size & CAGR, 2020 VS 2024 VS 2031
11.2 By Country, Global Lapatinib Ditosylate API Consumption Value, 2020-2031
11.3 By Country, Global Lapatinib Ditosylate API Sales Quantity, 2020-2031
11.4 United States
11.4.1 United States Lapatinib Ditosylate API Market Size, 2020-2031
11.4.2 by Type, United States Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.4.3 by Application, United States Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Lapatinib Ditosylate API Market Size, 2020-2031
11.5.2 by Type, Europe Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.5.3 by Application, Europe Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.6 China
11.6.1 China Lapatinib Ditosylate API Market Size, 2020-2031
11.6.2 by Type, China Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.6.3 by Application, China Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Lapatinib Ditosylate API Market Size, 2020-2031
11.7.2 by Type, Japan Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.7.3 by Application, Japan Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Lapatinib Ditosylate API Market Size, 2020-2031
11.8.2 by Type, South Korea Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.8.3 by Application, South Korea Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Lapatinib Ditosylate API Market Size, 2020-2031
11.9.2 by Type, Southeast Asia Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.9.3 by Application, Southeast Asia Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.10 India
11.10.1 India Lapatinib Ditosylate API Market Size, 2020-2031
11.10.2 by Type, India Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.10.3 by Application, India Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Lapatinib Ditosylate API Market Size, 2020-2031
11.11.2 by Type, Middle East & Africa Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031
11.11.3 by Application, Middle East & Africa Lapatinib Ditosylate API Sales Quantity Market Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Novartis
12.1.1 Novartis Company Information, Head Office, Market Area, and Industry Position
12.1.2 Novartis Lapatinib Ditosylate API Models, Specifications, and Application
12.1.3 Novartis Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Novartis Company Profile and Main Business
12.1.5 Novartis Recent Developments
12.2 Tecoland
12.2.1 Tecoland Company Information, Head Office, Market Area, and Industry Position
12.2.2 Tecoland Lapatinib Ditosylate API Models, Specifications, and Application
12.2.3 Tecoland Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Tecoland Company Profile and Main Business
12.2.5 Tecoland Recent Developments
12.3 Hetero
12.3.1 Hetero Company Information, Head Office, Market Area, and Industry Position
12.3.2 Hetero Lapatinib Ditosylate API Models, Specifications, and Application
12.3.3 Hetero Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Hetero Company Profile and Main Business
12.3.5 Hetero Recent Developments
12.4 Vannsh Life Sciences
12.4.1 Vannsh Life Sciences Company Information, Head Office, Market Area, and Industry Position
12.4.2 Vannsh Life Sciences Lapatinib Ditosylate API Models, Specifications, and Application
12.4.3 Vannsh Life Sciences Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.4.4 Vannsh Life Sciences Company Profile and Main Business
12.4.5 Vannsh Life Sciences Recent Developments
12.5 Natco Pharma
12.5.1 Natco Pharma Company Information, Head Office, Market Area, and Industry Position
12.5.2 Natco Pharma Lapatinib Ditosylate API Models, Specifications, and Application
12.5.3 Natco Pharma Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.5.4 Natco Pharma Company Profile and Main Business
12.5.5 Natco Pharma Recent Developments
12.6 Huirui Pharma
12.6.1 Huirui Pharma Company Information, Head Office, Market Area, and Industry Position
12.6.2 Huirui Pharma Lapatinib Ditosylate API Models, Specifications, and Application
12.6.3 Huirui Pharma Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.6.4 Huirui Pharma Company Profile and Main Business
12.6.5 Huirui Pharma Recent Developments
12.7 Shengda Pharmaceutical
12.7.1 Shengda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.7.2 Shengda Pharmaceutical Lapatinib Ditosylate API Models, Specifications, and Application
12.7.3 Shengda Pharmaceutical Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.7.4 Shengda Pharmaceutical Company Profile and Main Business
12.7.5 Shengda Pharmaceutical Recent Developments
12.8 Shijiazhuang Dingmin Pharmaceutical Sciences
12.8.1 Shijiazhuang Dingmin Pharmaceutical Sciences Company Information, Head Office, Market Area, and Industry Position
12.8.2 Shijiazhuang Dingmin Pharmaceutical Sciences Lapatinib Ditosylate API Models, Specifications, and Application
12.8.3 Shijiazhuang Dingmin Pharmaceutical Sciences Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.8.4 Shijiazhuang Dingmin Pharmaceutical Sciences Company Profile and Main Business
12.8.5 Shijiazhuang Dingmin Pharmaceutical Sciences Recent Developments
12.9 ScinoPharm Taiwan
12.9.1 ScinoPharm Taiwan Company Information, Head Office, Market Area, and Industry Position
12.9.2 ScinoPharm Taiwan Lapatinib Ditosylate API Models, Specifications, and Application
12.9.3 ScinoPharm Taiwan Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.9.4 ScinoPharm Taiwan Company Profile and Main Business
12.9.5 ScinoPharm Taiwan Recent Developments
12.10 Shandong Boyuan Pharmaceutical
12.10.1 Shandong Boyuan Pharmaceutical Company Information, Head Office, Market Area, and Industry Position
12.10.2 Shandong Boyuan Pharmaceutical Lapatinib Ditosylate API Models, Specifications, and Application
12.10.3 Shandong Boyuan Pharmaceutical Lapatinib Ditosylate API Sales Quantity, Revenue, Price and Gross Margin, 2020-2025
12.10.4 Shandong Boyuan Pharmaceutical Company Profile and Main Business
12.10.5 Shandong Boyuan Pharmaceutical Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Lapatinib Ditosylate API should grow from US$ 14.05 million in 2024 to US$ 18.62 million by 2031, with a CAGR of 4.1% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Lapatinib Ditosylate API

According to YH Research, the global market for Lapatinib Ditosylate API should grow from US$ 14.05 million in 2024 to US$ 18.62 million by 2031, with a CAGR of 4.1% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Lapatinib (INN), used in the form of lapatinib ditosylate, (USAN) (Tykerb/Tyverb, GSK) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor which interrupts the HER2/neu and epidermal growth factor receptor (EGFR) pathways. It is used in combination therapy for HER2-positive breast cancer. It is used for the treatment of patients with advanced or metastatic breast cancer whose tumors overexpress HER2 (ErbB2).In 2024, global Lapatinib Ditosylate API production reached approximately 4669 kg, with an average global market price of around US$ 2829 per kg.The average gross profit margin of this product is 23%.

The global growth of the Lapatinib Ditosylate API market is primarily driven by the rising incidence of breast cancer, the expansion of precision medicine, and the increasing adoption of multi-target combination therapies. Improved patient compliance with oral targeted therapies and the expansion of reimbursement systems further support demand. The expiration of key patents has encouraged generic manufacturers to enter the API production segment, leading to cost optimization and capacity expansion. Asian and Indian producers, leveraging process expertise and cost efficiency, are rapidly integrating into the global supply chain, promoting diversification and competition.The primary challenges include the complex synthesis process, difficulty in controlling polymorphism, and high production costs associated with purity standards. Regulatory scrutiny from agencies such as the EMA and FDA regarding impurities and crystalline consistency continues to intensify, increasing compliance burdens. Market competition has intensified following patent expirations, placing downward pressure on API pricing and profitability. Moreover, supply instability of key intermediates in certain regions has prompted manufacturers to strengthen local sourcing and raw material security strategies.

Downstream demand is shifting from single-target therapy to combination regimens integrating targeted and immunotherapies, where Lapatinib remains an important component. Clinical evidence shows that co-administration with trastuzumab or capecitabine significantly enhances efficacy, supporting stable growth in formulation demand. Expanding access to targeted breast cancer therapies in emerging markets is further stimulating API consumption. With the growing adoption of personalized medicine and the approval of more generic formulations, the Lapatinib Ditosylate API market is expected to evolve toward greater segmentation and industrial scale.

The synthesis of Lapatinib Ditosylate relies on several critical intermediates and reagents, including quinazoline-based core intermediates, aromatic amine derivatives, and toluenesulfonic acid salts. Fluctuations in raw material prices directly impact API cost structures. The optimization of solvent purity, crystal control agents, and impurity removal processes is essential for improving yield and quality consistency. With the advancement of green chemistry and continuous-flow manufacturing, several producers are adopting process innovations to minimize solvent consumption, enhance reproducibility, and promote sustainability.

This report studies and analyses global Lapatinib Ditosylate API status and future trends, helps the client to determine the Lapatinib Ditosylate API market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Lapatinib Ditosylate API, and provides market size (in kg & US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Lapatinib Ditosylate API market size, history data 2020-2025, and forecast data 2026-2031, (US$ million) & (kg)
(2) Global Lapatinib Ditosylate API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (kg)
(3) China Lapatinib Ditosylate API sales, revenue, price by company, market share and industry ranking 2020-2025, (US$ million) & (kg)
(4) Global Lapatinib Ditosylate API key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Lapatinib Ditosylate API key producing regions, capacity, production, and year over year growth
(6) Lapatinib Ditosylate API industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Novartis
Tecoland
Hetero
Vannsh Life Sciences
Natco Pharma
Huirui Pharma
Shengda Pharmaceutical
Shijiazhuang Dingmin Pharmaceutical Sciences
ScinoPharm Taiwan
Shandong Boyuan Pharmaceutical

Market segment by Type, covers
Lapatinib Ditosylate Hydrate
Anhydrous Lapatinib Ditosylate

Market segment by Production Process, covers
Chemical Synthesis Route
Continuous Flow Process
Other

Market segment by Product Type, covers
Crystalline Form
Amorphous Form

Market segment by Application, can be divided into
Research
Pharmaceutical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Lapatinib Ditosylate API product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Lapatinib Ditosylate API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 3: China Lapatinib Ditosylate API market share and ranking of major manufacturers, sales quantity, revenue, average price, 2020-2025
Chapter 4: Global key producing regions of Lapatinib Ditosylate API, percent & CAGR, 2020-2031
Chapter 5: Lapatinib Ditosylate API industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2020-2031
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.